Search Contact
This page is available in multiple languages
Select Language

Farmacosmo S.p.A. lists on Euronext Growth Milan

Back

  • Fourth listing of 2022 on Euronext Growth Milan
  • Farmacosmo S.p.A. brings the total number of companies listed on Euronext Growth Milan to 178
  • Total placement volume of the offering equal to €23 million

Milan – 30 March 2022 – Borsa Italiana, part of the Euronext Group, today congratulates Farmacosmo S.p.A. on its listing on Euronext Growth Milan.

Farmacosmo S.p.A. is a wellness e-commerce company active in the Health, Pharma and Wellness industry, authorised by the Italian Ministry of Health to sell pharmaceutical products online. 

Farmacosmo S.p.A. represents the fourth listing since the beginning of the year on Borsa Italiana’s market dedicated to small and medium sized companies, and it brings the total number of firms currently listed on Euronext Growth Milan to 178.

In the placement phase, Farmacosmo S.p.A. raised €20 million excluding the potential exercise of an over-allotment option. In the case of the full exercise of the over-allotment option, the total amount raised will be €23 million.

The free float at the time of admission was 26.57% and the market capitalisation at IPO was €75.3 million.

Fabio de Concilio, CEO of Farmacosmo S.p.A., said: "I am proud of this achievement we have reached. We started in a small office, a room and three employees. Step by step, counting only on our own strength, we have managed to get to where we are now; stable and solid, ready to face a new chapter in the life of Farmacosmo with the dedication, the foresight and the humility that have always been the cornerstones of our work. We will continue to dedicate ourselves to ensure that our customers will find Farmacosmo as a reference point for their wellness."

Farmacosmo S.p.A. - Euronext Growth Milan

Caption: Fabio de Concilio, CEO of Farmacosmo S.p.A.

About Farmacosmo S.p.A. Farmacosmo S.p.A. is a wellness e-commerce company active in the Health, Pharma and Wellness industry, authorised by the Italian Ministry of Health to sell pharmaceutical products online.  Farmacosmo has expanded the concept of online parapharmacy, from a "place" where you can buy products to cure yourself to a place where you can take care of yourself. The perfect synthesis of the name Farmacosmo: Pharma + Cosmetics. Customers have access to a constantly updated catalogue, with extremely competitive prices, which includes 65,000 products and 4,000 brands and is organised into 15 different product categories.

Download press release - Farmacosmo S.p.A. lists on Euronext Growth Milan

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €7.1 trillion in market capitalisation as of end March 2024, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2024, Euronext N.V. - All rights reserved.